Priced at $0.25 per share, compared with $4.10 closing price on May 12
By Susanna Moon
Chicago, May 16 – China Gewang Biotechnology Inc. wrapped a $4,375,000 private placement of stock with two investors, according to an 8-K filing with the Securities and Exchange Commission.
The company sold 17.5 million common shares at $0.25 per share, compared with the $4.10 closing price of the company’s stock on May 12.
The purchase price was paid to Guangdong Gewang Biotechnology Co., Ltd., which is managed by a wholly owned subsidiary of the company.
China Gewang sells selenium supplements and is based in Guangzhou, China.
| Issuer: | China Gewang Biotechnology Inc.
|
| Issue: | Common stock
|
| Amount: | $4,375,000
|
| Shares: | 17.5 million
|
| Price: | $0.25
|
| Warrants: | No
|
| Settlement date: | May 16
|
| Stock symbol: | OTCBB: CGWB
|
| Stock price: | $4.10 at close May 12
|
| Market capitalization: | $244.08 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
